Investing.com -- UBS Global Research has upgraded Trainline (LON:TRNT) to a "buy" rating, citing improved fundamentals and ...

Novo Nordisk's phase 1b/2a clinical trial results revealed that their investigational drug, amycretin, led to an average ...

Investing.com -- Verizon (NYSE: VZ) on Friday reported better-than-expected earnings and revenue for the fiscal fourth ...

Oil prices remained on track for a weekly loss on Friday, with sentiment dampened by US President Donald Trump's calls for ...

The new financing is expected to help Affirm meet its 2025 lending target of over $34 billion, a 25% increase from the ...

Investing.com - The US dollar has been on a tear since its late-September 2024 lows, and UBS thinks this near-term strength ...

Ahmedabad, Jan 24 (IANS) The Adani Group on Friday categorically denied reports claiming that Adani's 484 MW wind power projects in Mannar and Pooneryn in Sri Lanka have been cancelled.Terming such ...

Investing.com - Copenhagen-listed shares in Novo Nordisk (CSE: NOVOb) surged on Friday after the Danish drugmaker said ...

Group pre-close update suggested 2024 ended on a high,” said analysts at Jefferies in a note.  This is supported by the ...

According to Stifel, the Meta partnership positions EssilorLuxottica at the forefront of the smart glasses revolution. The ...

After facing criticism over Karnataka's non-participation in the World Economic Forum in Davos, the Siddaramaiah government has said the decision to stay away from the event was deliberate.Addressing ...

Investing.com -- The new year kicked off with another bang for stock market bulls, with the S&P 500 rallying a solid 4.2% month-to-date all the way into a new record-high close of 6,118 as of this ...